Introducing the ExPERT™ DTx™ System — scalable electroporation engineered for discovery. Learn more ×
Skip to content
  • Partner Portal Login
  • News & Events
    • Events
    • Latest News
    • Press Releases
  • Investors
MaxCyte Logo - Flat style. Blue M logo mark, White MaxCyte word logo. Blue spot inside the 'C' of MaxCyte word logo. Registered logo mark in white after the 'e'.
  • Products
  • Services
  • Our Approach
    • Partnerships
    • Collaboration
    • Scientific Technical Support
    • Regulatory & Quality Support
  • Applications
  • Learning Hub
    • Featured Science
    • Resource Library
    • Scientific Publications
    • Webinars & Presentations
    • On-Demand Seminars
    • What Cells Can I Use?
  • About Us
    • Our History
    • Our Team
    • Board of Directors
    • Join our Team
  • Contact Us
    • Ask the ExPERT
    • Request a Quote
    • Technical Support
    • Find a Distributor
Menu
Mobile logo
  • Products
    • Electroporation Systems
  • Services
    • Gene Editing Risk Assessment
    • Screening Assays
      • Guide Profiler™
      • Guide Select™
    • Nomination Assays
      • ONE-seq
      • DEUX-seq™
      • GUIDE-seq™
    • Confirmation Assays
      • Amplicon-seq™
      • SAFER Detection™
    • About SeQure DX™
  • Our Approach
    • Partnerships
    • Collaboration
    • Scientific Technical Support
    • Regulatory & Quality Support
  • Applications
    • Applications
  • Learning Hub
    • Featured Science
    • Resource Library
    • Scientific Publications
    • Webinars & Presentations
    • On-Demand Seminars
    • What cells can I use?
  • About Us
    • Our History
    • Our Team
    • Board of Directors
    • Join our Team
  • Partner Portal Login
  • News & Events
    • Press Releases
    • News
    • Events
  • Investors
  • Contact Us
    • Ask the ExPERT
    • Request a Demo
    • Request a Quote
    • Technical Support

Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells

Bispecific IgG production in single host cells has been a much sought-after goal to support the clinical development of these complex molecules.

Read More

Efficient Responses in a Murine Renal Tumor Model by Electroloading Dendritic Cells With Whole-Tumor Lysate

Electroporation of dendritic cells (DCs) with tumor lysate elicited greater antitumor responses in vitro and in vivo, using less lysate than standard coincubation. Electroloaded DCs had normal surface marker expression and matured into competent antigen-presenting cells. In a renal carcinoma (RENCA) model, mice were pretreated with lysate-loaded DCs before tumor challenge.

Read More

Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein

Combined with CRISPR-Cas9 technology and single-stranded oligodeoxynucleotides (ssODNs), specific single-nucleotide alterations can be introduced into a targeted genomic locus in induced pluripotent stem cells (iPSCs)

Read More

Electroporation Enables Oligonucleotide Delivery to Regulate Gene Expression in Friedrich’s Ataxia Patient-Derived Cells

Oligonucleotide drugs are an up-and-coming area of development that presents many possibilities for the personalized treatment of rare diseases.

Read More

Assay Development for Epigenetic Regulation of Histone 3 Lysine 36 Methylation using AlphaLISA

In the last several years the field of histone methylation biology has grown significantly. However, the development of new cellular assays for methylating and demethylating enzymes has lagged behind, relying largely on reporter or high content assays.

Read More

Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) remains a progressive and eventually lethal disease characterized by increased pulmonary vascular resistance because of loss of functional lung microvasculature, primarily at the distal (intracinar) arteriolar level.

Read More

A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells

The compelling need to provide adoptive cell therapy (ACT) to an increasing number of oncology patients within a meaningful therapeutic window makes the development of an efficient, fast, versatile, and safe genetic tool for creating recombinant T cells indispensable.

Read More

A Pilot Study of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination Combined With Sunitinib For Metastatic Renal Cell Carcinoma

Background Sunitinib, a tyrosine kinase inhibitor currently in use for the treatment of metastatic renal cell carcinoma (mRCC), has been reported to modulate immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) in addition to exerting anti-angiogenic effects.

Read More

A Scalable Cell-Loading System for Non-Viral Gene Delivery and Other Applications

Across many areas of biopharmaceutical development, the goal of consistently transfecting appropriate quantities of DNA into cells has often been a significant bottleneck.

Read More

Allosteric mechanism for KCNE1 modulation of KCNQ1 potassium channel activation

The Maxcyte STx delivered membrane proteins KCNQ1 and KCNE1 to CHO-K1 cells. High efficiency, transient co-transfection enabled the high-throughput data generation of an automated patch clamp system for time- and cost-efficient, automated electrophysiology and the construction of a new molecular model for potassium ion channel activation.

Read More
« Newer Posts
Older Posts »
Row seperator4 Shape Decorative svg added to top
Row footerwideWave Shape Decorative svg added to bottom
MaxCyte Logo - Flat style. Blue M logo mark, White MaxCyte word logo. Blue spot inside the 'C' of MaxCyte word logo. Registered logo mark in white after the 'e'.
Receive upcoming events, new resources and more in your inbox
Sign up to the newsletter

Products

Products
  • Electroporation Systems
    • DTx
    • GTx
    • ATx
    • STx
    • VLx
  • Consumables
    • Processing Assemblies
    • Reagents & Accessories
  • Our Electroporation Technology

Services

Services
  • Gene Editing Risk Assessment
    • Screening Assays
      • Guide Profiler™
      • Guide Select™
    • Nomination Assays
      • ONE-seq
      • DEUX-seq™
      • GUIDE-seq™
    • Confirmation Assays
      • Amplicon-seq™
      • SAFER Detection™
  • About SeQure

Our Approach

Our Approach
  • Partnerships
  • Collaboration
  • Scientific Technical Support
  • Regulatory & Quality Support

About Us

About Us
  • Our History
  • Our Team
  • Board of Directors
  • Join our Team

Applications

Applications
  • Applications
    • Cell Therapy
    • Cell Based Assays
    • Gene Editing
    • Viral Vector
    • Protein & Antibody Production
    • Vaccine Development
  • Industries
    • Cell & Gene Therapy
    • Discovery & Translational Research
    • Bioprocessing
Ask the ExPERT

Technical Support

© 2026 MaxCyte. All Rights Reserved.

  • Quality Systems
  • Privacy policy
  • Terms and Conditions
  • Legal Disclaimer
  • Trademarks

Electroporators

Matrix_open_left_large

DTx

Transfect primary cells and cell lines with minimal perturbation delivering reproducible, high transfection efficiency and cell viability.

STx_04_shadow@2x

STx

Transfect up to 20 billion cells with scalable static or Flow Electroporation®.

GTx_05_shadows@2x

GTx

Transfect up to 20 billion cells with our clinically validated and cGMP compliant Flow Electroporation®.

ATx_03_shadow-132@2x

ATx

From small to medium static Electroporation.

VLX-right-132@2x

VLx

For gram scale protein production.

Our Electroporation Technology

Consumables

PA-Top-Image@2x

Processing Assemblies

Achieve the desired scale and throughput with a range of consumable devices.

 

Hyclone-cytiva-small@2x

Reagents & Supporting Products

Complement your workflow with our flexible electroporation buffer formats and accessories.

Applications

Cell Therapy

Discover scalable engineering to enable safe and potent cell therapies.

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.

Protein & Antibody Production

Accelerate biotherapeutic development with transient expression for gram-scale protein production.

Cell Based Assays

Produce assay-ready cells faster with scalable electroporation.

Viral Vector

Transfect adherent or suspension cells to produce a variety of viral vectors.

Vaccine Development

Innovate vaccine research with our adaptable platform for production of recombinant proteins, virus-like particles.

Industries

Cell & Gene Therapy

Partnering with developers to accelerate development and scale cell therapy programs toward clinical success.

Discovery & Translational Research

Accelerating breakthrough discoveries with high-efficiency, reproducible electroporation across cell types.

Bioprocessing

Enabling efficient, reproducible transfection in virtually any cell type for high-yield transient expression and rapid cell line development.

Gene Editing Risk Assessment

About SeQure™

Screening Assays

Guide Profiler™

Guide Select™

Nomination Assays

ONE-seq

DEUX-seq™

GUIDE-seq™

Confirmation Assays

Amplicon-seq™

SAFER Detection™